Abstract
Intrathecal oligoclonal IgG antibodies (Abs) are present in more than 90% of multiple sclerosis (MS) patients and the presence of such Abs serves as a laboratory marker supporting the diagnosis of this disease. The intrathecal IgG fractions contain Abs with many different specificities, including myelin-specific Abs. Reports on anti-myelin Abs in cerebrospinal (CSF) and sera are controversial [1-7]. Several reports describe the presence of anti-myelin Ab in serum and CSF, whereas others find anti-myelin Abs only in the CSF, and yet others report that anti-myelin Abs are absent in MS patients. However, B lymphocytes specific for, and plasma cells secreting Abs to myelin basic protein (MBP), myelin-associated glycoprotein (MAG), myelin oligodendrocyte glycoprotein (MOG), and proteolipid protein (PLP) are consistently detected in the central nervous system (CNS) of MS patients [8-11]. Such cells are even found in the CSF in the absence of anti-myelin Abs, suggesting that antibodies rapidly bind to target structures, such as the corresponding auto-antigens or to Fcreceptors, and therefore become undetectable [8, 9]. In organotypic, myelinated cultures of CNS tissue, sera of MS patients promoted myelin breakdown [12]. Similar results were obtained using rabbit anti-galactocerebroside (GalC) sera and anti-whole myelin sera [13, 14]. Genain et al. [15] identified auto-antibodies against MOG within acute MS lesions, where they were associated with damaged myelin membranes, and within macrophages ingesting myelin [15]. Lassmann et al. [16] described abundant deposition of immunoglobulins in a subclass of active MS.
* This work has already been partially published in J Neuroimmunol 1999, 101:61-67
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Möller JR et al (1989) Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 22:55–61
Cruz M et al (1987) Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis. Neurology 37:1515–1519
Henneberg A et al (1991) Antibodies to brain tissue in sera of patients with chronic progressive multiple sclerosis. J Neuroimmunol 34:223–227
Bernard CCA et al (1981) Antibody to myelin basic protein in extracts of multiple sclerosis brain. Immunology 43:447–457
Ryberg B, Jacque C (1986) Are anti-brain antibodies in multiple sclerosis directed to myelin basic protein. Acta Neurol Scand 73:247–252
Wajgt A, Górny M (1983) CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies. Acta Neurol Scand 68:337–343
Xiao BX et al (1991) Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 31:91–96
Sun JB et al (1991) T and B cell responses to myelin-oligodendrocye glycoprotein in multiple sclerosis. J Immunol 146:1490–1495
Sun JB et al (1991) Autoreactive T and B cells responding to myelin proteolipid in multiple sclerosis and controls. Eur J Immunol 21:1461–1468
Baig S et al (1991) Multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid. Scand J Immunol 33:73–79
Link H et al (1990) Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid. J Neuroimmunol 28:237–248
Raine CS et al (1973) Multiple sclerosis: serum-induced demyelination in vitro. J Neurol Sci 20:127–148
Seil FJ (1968) The in vitro demyelinating activity of sera from guinea pigs sensitized with while CNS and with purified encephalitogen. Exp Neurol 22:545–555
Raine CS et al (1981) Demyelination in vitro: absorption studies demonstrate that galactocerebroside is a major target. J Neurolog Sci 52:117–131
Genain CP et al (1999) Identification of autoantibodies with myelin damage in multiple sclerosis. Nat Med 5:170–175
Lassmann H et al (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7:115–121
Morris MM et al (1998) Antibodies to myelin components modulate experimental allergic encephalomyelitis in Biozzi ABH (H-2Ag7) mice. Biochem Soc Trans 25:168S–173S
Linington C, Lassmann H (1987) Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol 17:61–69
Lassmann H et al (1981) In vivo effect of sera from animals with chronic relapsing experimental allergic encephalomyelitis on central and peripheral myelin. Acta Neuropathol (Berl) 55:297–306
Moore GRW et al (1984) Experimental autoimmune encephalomyelitis: augmentation of demyelination by different myelin lipids. Lab Invest 51:416–424
Linington C et al (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/ologodendrocyte glycoprotein. Am J Pathol 130:443–454
Schluesner HJ et al (1987) A monoclonal antibody against a myelin ologodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 139:4016–4021
Piddlesden SJ et al (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 143:555–564
Piddlesden SJ et al (1991) Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation. Exp Immunol 83:245–250
Piddlesden SJ et al (1994) Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J Immunol 152:5477–5484
Van der Goes A et al (1999) The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages. J Neuroimmunol 101:61–67
Abdul-Majid K et al (2002) Fc Receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand J Immunol 55:70–81
Lock C (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500–508
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Italia
About this chapter
Cite this chapter
Van Der Goes, A. et al. (2004). Antibody Mediated Demyelination. In: Hommes, O.R., Comi, G. (eds) Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis. Topics in Neuroscience. Springer, Milano. https://doi.org/10.1007/978-88-470-2117-4_16
Download citation
DOI: https://doi.org/10.1007/978-88-470-2117-4_16
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2171-6
Online ISBN: 978-88-470-2117-4
eBook Packages: Springer Book Archive